Intelligenome
Yuanyuan Kang is an accomplished research scientist with extensive experience in molecular and genomic sciences. Currently serving as the Director of Research Development at Intelligenome since November 2023, Yuanyuan previously held positions as a Senior Scientist at Precision For Medicine and Baylor Genetics, where responsibilities included leading teams in the development and validation of biomarker assays and providing technical support for clinical production. Prior research experience includes a Research Fellow role at Harvard Medical School and Massachusetts General Hospital, focusing on melanoma mechanisms, and a Postdoctoral Researcher position at the University of Colorado School of Medicine, investigating genetic and epigenetic regulation. Yuanyuan’s academic journey began with a PhD in Biochemistry and Molecular Biology from Jilin University.
This person is not in any teams
Intelligenome
IntelliGenome is a CRISPR molecular diagnostic start-up based in Houston, Texas. The company was founded in July 2022 with a commitment to commercialize an innovative CRISPR detection platform technology. Our mission is to revolutionize the field of disease diagnostics by harnessing the power of CRISPR technology. Our innovative platform enables direct measurement and quantification of active disease elements, providing healthcare providers with critical information for treatment monitoring and optimizing drug efficacy.